Operating Expenses Cambiamento Data
Abbott USD 8.45B 21M 2023-12
Acorda Therapeutics USD 33.31M 427K 2023-06
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
Enanta Pharmaceuticals USD 49.96M 5.64M 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Heron Therapeutics USD 56.36M 17.8M 2023-09
Insmed USD 261.96M 35.22M 2023-12
Integra LifeSciences USD 361.11M 5.16M 2023-12
Intrexon USD 22.32M 571K 2023-09
J&J USD 16.57B 435M 2023-12
Ligand Pharmaceuticals USD 31.56M 1.77M 2023-12
Merit Medical Systems USD 280.09M 11.15M 2023-09
Peregrine Pharmaceuticals USD 36.62M 3.27M 2023-09
Rigel Pharmaceuticals USD 32.6M 446K 2023-09
Smith & Nephew USD 2.46B 52M 2023-06
Stryker USD 4.56B 580M 2023-12
Surmodics USD 30.42M 651K 2023-09
Veracyte USD 133.71M 11.86M 2023-12
Xencor USD 79.7M 2.27M 2023-12
Zimmer Biomet Holdings USD 1.59B 98.9M 2023-12



Anika Therapeutics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.